Nebraska § 71-9603 Eligible patient

Nebraska Statutes

§ 71-9603 — Eligible patient

Nebraska·Ch. 71 Public Health and Welfare

To be an eligible patient under the Investigational Drug Use Act, a person shall:

(1)Have an advanced illness, attested by the person's treating physician;

(2)Have considered all other treatment options approved by the United States Food and Drug Administration at the time;

(3)Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;

(4)Give written, informed consent for the use of the investigational drug, biological product, or device;

(5)Have documentation from his or her treating physician that he or she meets the requirements of the act; and

(6)Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.

Free access — add to your briefcase to read the full text and ask questions with AI

To be an eligible patient under the Investigational Drug Use Act, a person shall:
(1) Have an advanced illness, attested by the person's treating physician;
(2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time;
(3) Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;
(4) Give written, informed consent for the use of the investigational drug, biological product, or device;
(5) Have documentation from his or her treating physician that he or she meets the requirements of the act; and
(6) Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.

Nebraska § 71-9603 (Eligible patient) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.